Intervacc is trading at €0.08 (-16.17%) with no fresh company-specific announcement or reliable report directly explaining the decline.
- The decline came despite flat major U.S. indices and mildly constructive global-market sentiment on August 10, 2026.
- Recent developments—Strangvac’s New Zealand import approval and the EMA 12-month immunity application—predate the decline and do not establish causation.
- August 7 was the latest completed trading session; volume and activity details were unavailable.